magrolimab,azacitidine
gilead sciences
['leusm', 'aml,(-streamline),(-seamless),(-kamloops)']
#asco22 #leusm strickland: aza/magro in tp53m aml. ~30% had gr3+ anemia (on target toxicity which needs to be managed with transfusion). 41.7% cr/cri, 33% cr (50% of which were mrd neg) 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)